🚀
Enjoy a 7-Day Free Trial Thru Apr 26, 2024!
✨
Sign Up
Login
Free Sign-up
Login
7-Day Free Trial
Home
Homepage
Membership Levels
About Us
General Discussion
Complete Stock List
The book
Membership Data Coverage
Founder's Message
Free Trial
Referral Program
Partner Program
GuruFocus Podcast
Screeners
GuruFocus Screeners
All-In-One Screener
Ben Graham Lost Formula
Canadian Faster Growers
CEO Buys
CEO Buys after Price Drop > 20%
Dividend Kings 2023
Dividend Aristocrats 2023
Dividend Growth Portfolio
Dividend Income Portfolio
Fast Growers
Good Companies
Hedge Fund Guru Top 10 Aggregated
High Quality
High Quality Low Capex w ROE ROC min
High Quality & Low Capex
High Yield Insider Buys
Historical High Dividend Yields
International Gurus' Top Holdings
James Montier Short Screen
Margin Decliners
Mega Caps
Peter Lynch & Warren Buffett
Peter Lynch Growth w Lower Valuation
Peter Lynch S&L Traded Below Book
PFCF Screener
Piotroski Score Screener
Predictable Growth Companies
Profitable predictable margin expanders
Stocks Sold w less Cash
The Stalwarts
My Screeners
Create My Screener
Value Screens
Stock Ideas
All-In-One Screener
S&P 500 Map
S&P 500 Bubble
S&P 500 Aggregate
Buffett-Munger Screener
Industry Overview
Undervalued Predictable
Benjamin Graham Net-Net
52-week/3Y/5Y Lows
52-week/3Y/5Y Highs
Magic Formula(Greenblatt)
Dividend Stocks
Peter Lynch Screen
S&P500 Grid
Predictable Companies
Spin Off List
Merger and Acquisition List
Historical Low P/B List
Historical Low P/S List
High Short Interest
Upcoming Special Dividends
Delisted Stocks
Model Portfolios
Performances Overview
Most Broadly Held Portfolio
Most Weighted Portfolio
Buffett-Munger Top 25
GF Score <= 100 Top 25
Top 25 Undervalued Predictable
Top 25 52-week Low Predictable
Top 25 Historical Low P/S
Stock Comparison
Airline Stocks
Artificial Intelligence Stocks
Bank Stocks
Biotech Stocks
Blockchain Stocks
Chinese Stocks
Dividend Stocks
EV Stocks
Growth Stocks
Oil Stocks
Value Stocks
Virtual Reality Stocks
Compare More Stocks…
Gurus
Guru Trades
Latest Guru Picks
Real Time Picks
Guru Portfolio
Score Board
Mutual Funds
Top 10 Holdings
Sector Picks
International Picks
Aggregated Portfolio
Consensus Picks
Guru Bargains
Hot Picks
Download Guru Portfolios
Industry Trends
Geographic Trend
ETFs
Options Holdings
European Shorting
Guru Lists
Complete Guru List
Warren Buffett
Bill Gates
Mohnish Pabrai
Carl Icahn
George Soros
David Tepper
Seth Klarman
Bill Ackman
Joel Greenblatt
Charlie Munger
Michael Price
Julian Robertson
Chuck Akre
David Einhorn
Tom Gayner
My Guru Lists
Insiders
Insider Trading Tracker
Real-Time Insider Picks
CEO Buys/Sells
CFO Buys/Sells
Insider Trends
Insider Cluster
Guru + Insider Double Buys
Triple Buys/Sells
Chinese Insider
German Insider
Complete Insider List
Politician Trading Tracker
Real-Time Politician Picks
Complete Politician List
Nancy Pelosi
Mitch Mcconnell
Tommy Tuberville
Josh Gottheimer
Kevin Hern
Thomas R. Carper
Susie Lee
Lois Frankel
Market
US Market Valuation
Buffett Indicator
U.S. Treasury Yield Curve
U.S. Inflation Rate
Presidential Cycle and Stock Market
Shiller P/E
Shiller P/E by Sectors
GF Value for S&P 500 Index
Fed Net Liquidity
Buffett Assets Allocation
Latest IPOs
Global Market Valuation
Global Market Overview
USA
China
Japan
India
Canada
UK
France
Germany
Brazil
Australia
More...
Economic Indicators
Economic Indicators Overview
The Dow Jones Industrial Average (DJIA)
SP 500 Index
Nasdaq Composite Index
Gross Domestic Product (GDP)
Shiller PE
Ratio of Wilshire 5000 over GNP
Civilian Unemployment Rate
Russell 2000 Index
CBOE Volatility Index (VIX)
Total Nonfarm Payrolls: All Employees
More...
Sector & Industry Performance
Global Industry Overview
USA
Asia
Europe
Canada
UK/Ireland
Oceania
Latin America
Africa
India/Pakistan
Articles
Articles
Editors' Picks
Stock Market News
Q&A with Gurus
Guru Stock Picks
Insider Transaction
Earning Reports
CEO Shareholder Letters
Podcast
Earnings Call Transcripts
Software Stock News
Biotechnology Stock News
Hardware Stock News
Banks Stock News
Metals & Mining Stock News
Drug Manufacturers Stock News
All Articles
Submit Articles
Submit Article Online
Contributor Guidelines
Tools
Model Portfolios
All-In-One Screener
Data Batch Download
Guru Portfolio Download
Insider Data Download
Excel Add-In
Google Sheets Add-On
API
Manual of Stocks
DCF Calculator
WACC Calculator
Interactive Chart
Maps
Fund Letters Archive
Stock Comparison Table
Mobile App
Discussion Board
GuruGPT
Financial Calendar
Embed Widgets
Stock Market Holidays
Discussion
Discussion Board
GuruFocus Discord
ETF
Data
Pricing
Tutorials
Tutorials
Financial Glossary
FAQ
Change Log
Contact Us
Support
Chat Support
Create a ticket
Book Demo
User Engagement Meeting
469-248-6885
Status
Take Survey
Ask the community in Discord
Subscribe
Free Trial
Group Subscription
Refer a Friend and Earn One Month of Free Membership
GURUFOCUS.COM
STOCK LIST
Healthcare
Biotechnology
Adial Pharmaceuticals Inc (NAS:ADILW)
News
Adial Pharmaceuticals Inc - Warrants (31/07/2023
(Warrants)
NAS
:ADILW (USA) Â
Warrants (31/07/2023)
$ 0.00
0 (0%)
03:52 PM EST
P/E:
At Loss
P/B:
0.88
Market Cap:
$ -
Enterprise V:
$ -
Volume:
-
Avg Vol (2M):
-
Warning! GuruFocus detected 1 Severe warning sign with ADILW.
Try a 7-Day Free Trial
to check it out.
Volume:
-
Market Cap $:
-
PE Ratio:
At Loss
Avg Vol (2M):
-
Enterprise Value $:
-
PB Ratio:
0.88
Alerts
Website
SEC Filings
Stock PDF
Dataset
Financial Download
Manual of Stocks™
Compare
0
Summary
30-Y Financials
DCF
Dividend
Guru Trades
Insider
Interactive Chart
Filings
Transcripts
News
Compare
Stock PDF
Ownership
Operating
Checklist
Vote
Definitions
Adial Pharmaceuticals Inc (NAS:ADILW) Stock News, Headlines & Updates
Adial Pharmaceuticals Inc Stock News from GuruFocus
Total 169
1
2
3
4
5
Apr 10, 2024
Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
Marketwired
•
8:00am
Feb 15, 2024
Adial Pharmaceuticals to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20
ACCESSWIRE
•
11:00am
Feb 06, 2024
Adial Pharmaceuticals Inc at The Fall Foliage MicroCap Rodeo Conference Transcript
GuruFocus Research
•
6:19pm
Adial Pharmaceuticals Inc at HC Wainwright Investment Conference - New York Transcript
GuruFocus Research
•
6:19pm
Adial Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
GuruFocus Research
•
6:19pm
Adial Pharmaceuticals Inc at ROTH Conference Transcript
GuruFocus Research
•
6:19pm
Adial Pharmaceuticals Inc To Provide An Update On Its Regulatory And Partnering Strategy For The United States And Europe-Call Transcript
GuruFocus Research
•
6:19pm
Adial Pharmaceuticals Inc Business Update Call Transcript
GuruFocus Research
•
6:19pm
Adial Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) Transcript
GuruFocus Research
•
6:19pm
Adial Pharmaceuticals Inc Business Update Call Transcript
GuruFocus Research
•
6:19pm
Nov 14, 2023
Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
•
5:00pm
Oct 24, 2023
Adial Pharmaceuticals Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Marketwired
•
4:00pm
Oct 20, 2023
Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Marketwired
•
8:00am
Oct 19, 2023
Adial Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference on October 25th
ACCESSWIRE
•
3:00pm
Adial Pharmaceuticals Awarded Notice of Allowance for Key Patent Combining Use of the Company's Proprietary Genetic Diagnostic with AD04 to Treat Alcohol and Drug Dependence
Marketwired
•
10:00am
Oct 18, 2023
Adial Pharmaceuticals Wins Frost & Sullivan's 2023 North American Precision Medicine for Addiction Disorders Technology Innovation Leadership Award
Marketwired
•
7:00am
Sep 28, 2023
Adial Pharmaceuticals to Host a Virtual Key Opinion Leader Webinar to Discuss the Unmet Need in Alcohol Use Disorder
Marketwired
•
6:00am
Sep 05, 2023
Adial Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Marketwired
•
8:00am
Aug 28, 2023
Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss the Need for New Alcohol Use Disorder Treatments at the European Society for Biomedical Research on Alcoholism
Marketwired
•
8:00am
Aug 23, 2023
Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
Marketwired
•
8:00am
Aug 21, 2023
Adial Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update
Marketwired
•
8:00am
Aug 15, 2023
Thinking about buying stock in Rivian Automotive, Joby Aviation, Research Solutions, Galera Therapeutics, or Adial Pharmaceuticals?
PRNewswire
•
9:00am
Aug 04, 2023
Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price Requirement and Reduce the Public Float
Marketwired
•
8:00am
Jul 11, 2023
Adial Provides Business Update Following Favorable Comments from US and EU Regulatory Meetings
Marketwired
•
8:00am
Mar 02, 2023
Adial Pharmaceuticals Schedules Business Update Conference Call
sperokesalga
•
8:00am
Feb 27, 2023
Adial Pharmaceuticals Announces Closing of $0.75 Million At-The-Market Registered Direct Offering
sperokesalga
•
8:00am
Feb 24, 2023
Adial Pharmaceuticals Announces Pricing of $0.75 Million At-The-Market Registered Direct Offering
sperokesalga
•
6:00am
Nov 14, 2022
Adial Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
Value_Insider
•
8:00am
Aug 22, 2022
Adial Pharmaceuticals Names Cary Claiborne as Chief Executive Officer
PurpleRose
•
4:00pm
Aug 16, 2022
Adial Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results
PurpleRose
•
9:00am
Jul 20, 2022
Adial Pharmaceuticals Announces Topline Results For Onward™ Phase 3 Trial for AD04 in Patients with Alcohol Use Disorder
PurpleRose
•
7:00am
Jul 14, 2022
Adial Pharmaceuticals Awarded Additional U.S. Patent Combining the Use of the Company's Proprietary Genetic Diagnostic With AD04 to Treat Alcohol and Drug Dependence
PurpleRose
•
10:28am
Jul 08, 2022
Adial Pharmaceuticals Provides Letter to Shareholders From CEO William Stilley
GuruFocusNews
•
11:35am
Adial Pharmaceuticals Announces Research Collaboration with the Medical College of Wisconsin to Advance Purnovate's Adenosine Compounds as Potential Treatments for Diabetes and NASH
GuruFocusNews
•
10:14am
Jul 07, 2022
Adial Pharmaceuticals Announces Database Lock for the ONWARD™ Phase 3 Clinical Trial
GuruFocusNews
•
8:38am
Jul 04, 2022
Adial Pharmaceuticals Awarded Additional U.S. Patent Combining the Use of the Company's Proprietary Genetic Diagnostic With AD04 to Treat Alcohol and Drug Dependence
GuruFocusNews
•
10:27am
Jun 28, 2022
Adial Pharmaceuticals Provides Letter to Shareholders From CEO William Stilley
GuruFocusNews
•
11:30am
Jun 27, 2022
Adial Pharmaceuticals Announces Database Lock for the ONWARD™ Phase 3 Clinical Trial
GuruFocusNews
•
8:32am
Jun 24, 2022
Adial Pharmaceuticals Awarded Additional U.S. Patent Combining the Use of the Company's Proprietary Genetic Diagnostic With AD04 to Treat Alcohol and Drug Dependence
GuruFocusNews
•
10:25am
Jun 14, 2022
Adial Pharmaceuticals Awarded Additional U.S. Patent Combining the Use of the Company's Proprietary Genetic Diagnostic With AD04 to Treat Alcohol and Drug Dependence
GuruFocusNews
•
10:24am
Total 169
1
2
3
4
5
Show
20
40
60
80
100
No data
Entries
Headlines
Total 0
1
No recent news